2004
DOI: 10.1016/j.amjhyper.2004.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Relationship between insulin resistance and end-organ damage in white coat hypertension

Abstract: A possible relationship between end-organ damage and insulin resistance in patients with WCH exists.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

2007
2007
2020
2020

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 37 publications
1
9
0
Order By: Relevance
“…Thus, we agree to previous studies that they indicate a possible relationship between end-organ damage and insulin resistance in patients with white coat hypertension exists [16, 17]. The association between white-coat hypertension and metabolic disturbances of insulin-resistance syndrome may help explain the high prevalence of cardiovascular disease often associated with white coat hypertension [1820].…”
Section: Discussionsupporting
confidence: 92%
“…Thus, we agree to previous studies that they indicate a possible relationship between end-organ damage and insulin resistance in patients with white coat hypertension exists [16, 17]. The association between white-coat hypertension and metabolic disturbances of insulin-resistance syndrome may help explain the high prevalence of cardiovascular disease often associated with white coat hypertension [1820].…”
Section: Discussionsupporting
confidence: 92%
“…20 Interestingly, in a recent study patients with WCH and LVH were more insulin-resistant than those without LVH. 29 Other potential biologic mediators of LV hypertrophy in subjects with MetS may be certain peptide hormones, such as angiotensin II and leptin, which are secreted by white adipose tissue. 20 Our findings also suggest that the clustering of features of MetS, frequently described in WCHs, may be at least in part responsible for the cardiac abnormalities, and probably for the increased cardiovascular risk displayed in some, but not all, series regarding subjects with WCH [3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] .…”
Section: Discussionmentioning
confidence: 99%
“…The formula HOMA-IR = fasting glucose (mmol/L) * fasting insulin (mU/L) / 22.5 has been applied for calculation purposes [13].…”
Section: Methodsmentioning
confidence: 99%
“…The BMI has been calculated by the weight (kg) / height² (m) formula [13]. Overweight has been determined as BMI ≥25-29.9 kg/m 2 and obesity as BMI ≥ 30 kg/m 2 [11].…”
Section: Subjectsmentioning
confidence: 99%